By introducing selectively modified CTCL-related genes in skin-homing CD4+T cells with inflammation, the next top mouse models pave the way for exploring gene effects and understanding the genesis of early-stage CTCL. This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.